Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia
J Kaeda, A Chase, JM Goldman - Acta haematologica, 2002 - karger.com
… , the reverse-transcriptase polymerase chain reaction (RT-… In the early 1990s a number of
groups developed competitive … of interferon-alpha in the treatment of chronic myeloid leukemia…
groups developed competitive … of interferon-alpha in the treatment of chronic myeloid leukemia…
Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate
M Hardling, Y Wei, L Palmqvist, B Swolin… - Medical oncology, 2004 - Springer
… information about the efficiency of therapy, especially in patients with a … chronic myelogenous
leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction…
leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction…
Molecular monitoring 101: helping your patients with chronic myeloid leukemia to understand the meaning of molecular response
EJ Jabbour, A Quintás-Cardama - Leukemia & lymphoma, 2012 - Taylor & Francis
… -time quantitative polymerase chain reaction assessments of … molecular responses and
mutation monitoring. The aim of … (DASISION) demonstrated improved efficacy versus imatinib at …
mutation monitoring. The aim of … (DASISION) demonstrated improved efficacy versus imatinib at …
[HTML][HTML] Monitoring chronic myeloid leukemia patients responding to treatment with tyrosine kinase inhibitors by real-time quantitative polymerase chain reaction
… was to evaluate the efficacy of a treatment protocol and to … patients were pretreated with
busulfan or interferon-alpha, … A hypothetical mechanism could be competition with IM for a …
busulfan or interferon-alpha, … A hypothetical mechanism could be competition with IM for a …
[HTML][HTML] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes, J Kaeda, S Branford… - … England Journal of …, 2003 - Mass Medical Soc
… reverse-transcriptase polymerase chain reaction (PCR) has allowed patients in complete …
RNA and for differences in the efficiency of the reverse-transcriptase reaction. Nested PCR …
RNA and for differences in the efficiency of the reverse-transcriptase reaction. Nested PCR …
Chronic myelogenous leukaemia (CML): an update
L Kumar - The National medical journal of India, 2006 - repository.ias.ac.in
… dose schedules with monitoring of the white cell count. … It acts as a competitive inhibitor
of the ATP binding site on the … efficacy of an indigenous recombinant interferon-alpha-2b in …
of the ATP binding site on the … efficacy of an indigenous recombinant interferon-alpha-2b in …
MONITORING OF BUFFY COAT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH QUANTITA TIVE POLYMERASE CHAIN REACTION (PCR)
SNM Schmidt, ULDHW Siegert, A Neubauer - karger.com
… and efficiently detected after reverse transcription into cDNA by … Coamplification did not
show any competition between the … Most patients (n=26) were on interferon alpha (a-IFN) or …
show any competition between the … Most patients (n=26) were on interferon alpha (a-IFN) or …
Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia
F Campanini, MA Santucci, L Pattachini… - …, 2001 - haematologica.org
… their resistance to interferon-alpha or tyrosine kinase inhibitors. … in liquid culture or plating
efficiency in semisolid culture medium (… monitoring of residual disease in chronic myelogenous …
efficiency in semisolid culture medium (… monitoring of residual disease in chronic myelogenous …
Molecular monitoring of BCR–ABL as a guide to clinical management in chronic myeloid leukaemia
T Hughes, S Branford - Blood reviews, 2006 - Elsevier
… were established for patients on interferon alpha. They have … the competitive PCR assays
for monitoring treatment response, … chromosome-positive chronic myelogenous leukemia: high …
for monitoring treatment response, … chromosome-positive chronic myelogenous leukemia: high …
… BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone …
JC Chomel, F Brizard, A Veinstein… - Blood, The Journal …, 2000 - ashpublications.org
… -polymerase chain reaction (Q-RT-PCR) methods to study minimal residual disease in 3
patients with CML in … After treatment with IFN-α or allogeneic BMT, the monitoring of the residual …
patients with CML in … After treatment with IFN-α or allogeneic BMT, the monitoring of the residual …